Integrative Advances in Parkinson's Disease: Pathophysiology, Diagnostics, Therapeutics, and Experimental Modeling
Restorative Neurology and Neuroscience · 2026-08 · 44 (3) · 289-310
DOI: 10.1177/09226028261436622 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Restorative Neurology and Neuroscience, online erschienen am 20.04.2026. Verfasst von Kaushik Sunder. Beteiligte Einrichtung: NYU Office of the Provost, New York University, New York, NY, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Disease Models, Animal. Die Arbeit nennt 137 Literaturangaben.
Abstract (Originalsprache)
Background
Parkinson's disease (PD) is a neurodegenerative disorder characterized by loss of dopaminergic neurons and α-synuclein accumulation. Despite extensive research, there remains a shortage of effective disease-modifying medicines, which is due in part to the failure to translate molecular insights into clinically useful models and diagnostics.
Objectives
This review will summarize recent developments in the PD pathophysiology and diagnostic, therapeutic and experimental models and will focus on the newer in vivo , in vitro and bioengineered in vivo platforms.
Methods
Recent studies on animal models, patient-induced pluripotent stem cell (iPSC) systems, three-dimensional (3D) bioprinting, neuroimaging, and biomarker discovery have been critically examined to determine their translational potential and limitations.
Results
Traditional animal models are effective at replicating dopaminergic degradation but fall short of fully replicating progressive and systemic elements of Parkinson's disease. iPSC-derived neurons and 3D-bioprinted constructs are more genetically specific and cellularly complex, allowing for patient-relevant modeling and medication screening. Advances in imaging and molecular biomarkers aid in earlier detection; nevertheless, no cross-validation or platform standards has been established.
Conclusion
Combining cellular, molecular, and bioengineered models with clinical diagnostics has the potential to improve translational accuracy and accelerate the development of disease-modifying treatments. A cross-platform system is critical for improving the predictive validity of preclinical studies in Parkinson's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NYU Office of the Provost, New York University, New York, NY, USA.
ORCID-Profile: Kaushik Sunder
Zitieren
APA
Sunder, K. (2026). Integrative Advances in Parkinson's Disease: Pathophysiology, Diagnostics, Therapeutics, and Experimental Modeling. Restorative Neurology and Neuroscience, 44(3), 289-310. https://doi.org/10.1177/09226028261436622
Vancouver
Sunder K. Integrative Advances in Parkinson's Disease: Pathophysiology, Diagnostics, Therapeutics, and Experimental Modeling. Restorative Neurology and Neuroscience. 2026;44(3):289-310. doi:10.1177/09226028261436622
BibTeX
@article{Sunder2026,
author = {Sunder, Kaushik},
title = {Integrative Advances in Parkinson's Disease: Pathophysiology, Diagnostics, Therapeutics, and Experimental Modeling},
journal = {Restorative Neurology and Neuroscience},
year = {2026},
volume = {44},
number = {3},
pages = {289--310},
doi = {10.1177/09226028261436622}
}
EUVIMED